Skip to main
ISRG
ISRG logo

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 40 analyst ratings
Buy
Strong Buy 38%
Buy 33%
Hold 23%
Sell 3%
Strong Sell 5%

Bulls say

Intuitive Surgical has demonstrated strong financial performance with a revenue increase of 25% year-over-year, reaching $2.41 billion, and an 18% growth in da Vinci procedures, indicating robust market demand for its robotic surgery systems. The company benefits from an established global installed base of over 9,500 da Vinci systems, with significant opportunities for expansion in emerging markets and additional procedure growth driven by broadening indications and advancements in instrumentation. Given the company's continued innovation, steady utilization increases, and geographic expansion, there is a strong outlook for sustained revenue and earnings growth in the coming years.

Bears say

The financial analysis of Intuitive Surgical reveals a negative outlook primarily due to disappointing guidance on gross margins and operational expenses, with the company's projected gross margin for FY '25 falling short of analyst models. Additionally, certain segments, such as adjusted bariatrics volumes, experienced a decline year-over-year, indicating potential challenges in sustaining growth and market acceptance for new robotic platforms. External factors, including macroeconomic uncertainty affecting hospital budgets and tariffs on imports, further complicate the company's ability to capitalize on its installed base and drive future revenue growth.

Intuitive Surgical (ISRG) has been analyzed by 40 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 33% recommend Buy, 23% suggest Holding, 3% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 40 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Jul 1, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $529.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $529.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.